QuickView for Thy-1;jsessionid=011CF923678866240A0AFA39DB3FF7BC;jsessionid=FA5D1DB9947302AFBD75E63520EC7676;jsessionid=B4D3B8850707280A0F4F7B8340BA4982;jsessionid=D968CE5F4FF8CFC8B8D4F37E432CA912 (gene)

1. CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for …
2. An Anti-CD7 Antibody-Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leu…
3. Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
4. Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblas…
5. Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplant…

There were no clinical trials for Thy-1;jsessionid=011CF923678866240A0AFA39DB3FF7BC;jsessionid=FA5D1DB9947302AFBD75E63520EC7676;jsessionid=B4D3B8850707280A0F4F7B8340BA4982;jsessionid=D968CE5F4FF8CFC8B8D4F37E432CA912